Jorge L. Yao - Concepedia

Author

Jorge L. Yao

University of Rochester Medical Center

Also Known As

Jorge L Yao, Jorge L. Yao, Jorge Yao

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

University of Rochester Medical Center University of Rochester Indiana University – Purdue University Indianapolis Indiana University School of Medicine New York University

About

Jorge L. Yao is an author at University of Rochester Medical Center specializing in medicine, urology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	32	2.9K
2	Engineering	3	3	211
3	Public Health	2	2	59
4	Health Sciences	1	1	24
5	Biomedical Engineering	1	1	10

Jorge L. Yao

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy Edward M. Messing, Judith Manola, Jorge L. Yao, The Lancet Oncology Androgen Deprivation TreatmentUrologySurgical OncologyMedicineRadical Prostatectomy	2006	899
Androgen receptor is a tumor suppressor and proliferator in prostate cancer Yuanjie Niu, Saleh Altuwaijri, Kuo‐Pao Lai, Proceedings of the National Academy of Sciences Androgen ReceptorCancer BiologyTumor BiologyCancer Cell BiologyRadiation Oncology	2008	255
Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder Hiroshi Miyamoto, Jorge L. Yao, Alcides Chaux, British Journal of Urology	2012	223
Small Cell Carcinoma of the Prostate: An Immunohistochemical Study Jorge L. Yao, Ralph Madeb, Patricia Bourne, The American Journal of Surgical Pathology Classic ScpcUrologyOncologyPotential Therapeutic TargetsGenitourinary Cancer	2006	200
Near Infrared Fluorescence Imaging With Robotic Assisted Laparoscopic Partial Nephrectomy: Initial Clinical Experience for Renal Cortical Tumors Scott Tobis, Joy Knopf, Christopher Silvers, The Journal of Urology LaparoscopySurgical OncologyEngineeringOncologic ImagingMinimally Invasive Procedure	2011	166
ERG–TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin Sean R. Williamson, Shaobo Zhang, Jorge L. Yao, Modern Pathology Tumor BiologyConcurrent Prostatic AdenocarcinomaUrologyGenitourinary CancerPathology	2011	135
Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi‐institutional study Carmen Mir, Shahrokh F. Shariat, Theodorus van der Kwast, British Journal of Urology	2010	131
Immunohistochemical characterization of neuroendocrine cells in prostate cancer Jiaoti Huang, Jorge L. Yao, Paul A. di Sant'Agnese, The Prostate	2006	121
Combination of Napsin A and TTF-1 Immunohistochemistry Helps in Differentiating Primary Lung Adenocarcinoma From Metastatic Carcinoma in the Lung Jiqing Ye, Jennifer J. Findeis-Hosey, Qi Yang, Applied immunohistochemistry & molecular morphology	2011	115
Differential Expression of Interleukin-8 and Its Receptors in the Neuroendocrine and Non-Neuroendocrine Compartments of Prostate Cancer Jiaoti Huang, Jorge L. Yao, Li Zhang, American Journal Of Pathology UrologyDifferential ExpressionHormonal ReceptorImmunologyNeuroendocrine Disorder	2005	106

Page 1